Ravelli Flavia, Branzoli Stefano, Cristoforetti Alessandro, Quintarelli Silvia, Coser Alessio, Moggio Paolo, La Meir Mark, de Asmundis Carlo, Pannone Luigi, Onorati Francesco, Bonmassari Roberto, Marini Massimiliano
Laboratory of Biophysics and Translational Cardiology, Department of Cellular, Computational and Integrative Biology (CIBIO), Centre for Medical Sciences (CISMed), University of Trento, 38123 Trento, Italy.
Department of Cardiac Surgery, S. Chiara Hospital, APSS PA of Trento, 38122 Trento, Italy.
J Cardiovasc Dev Dis. 2025 Aug 19;12(8):313. doi: 10.3390/jcdd12080313.
Atrial fibrillation (AF), the most prevalent sustained cardiac arrhythmia, poses a significant burden on global morbidity and healthcare expenditure. Although endocardial catheter ablation and surgical ablation are established therapeutic strategies, each exhibits inherent limitations in achieving comprehensive substrate modification. Hybrid ablation therapy, integrating both endocardial and epicardial approaches, aims to overcome these limitations by enabling the more extensive and transmural targeting of arrhythmogenic foci and the complex atrial substrate. This review synthesizes the electrophysiological basis and mechanistic rationale underpinning hybrid AF ablation, highlighting its potential for an enhanced efficacy compared to isolated techniques. Furthermore, it introduces the emerging paradigm of three-dimensional ablation within this evolving field.
心房颤动(AF)是最常见的持续性心律失常,给全球发病率和医疗保健支出带来了巨大负担。虽然心内膜导管消融和手术消融是既定的治疗策略,但每种方法在实现全面的基质改良方面都存在固有局限性。混合消融疗法结合了心内膜和心外膜方法,旨在通过更广泛、透壁地靶向致心律失常病灶和复杂的心房基质来克服这些局限性。本综述综合了混合性房颤消融的电生理基础和机制原理,强调了其与单独技术相比提高疗效的潜力。此外,它还介绍了这一不断发展领域中新兴的三维消融模式。